MedCity News April 3, 2024
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in collaboration with Mayo Clinic, is embedded into Eko’s digital stethoscopes.
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure.
About 6.2 million Americans battle heart failure, with many of them experiencing low ejection fraction, a condition that occurs when the heart muscle pumps out less blood than normal during each contraction.
Conventional methods for detecting reduced ejection fraction, such as echocardiography, are often unavailable in...
Today's Sponsors
Today's Sponsor